Rosacea Explained: What’s Actually Causing That Persistent Redness – and Why It’s Not Acne

Rosacea is one of the most misdiagnosed and most undertreated skin conditions in the United States – affecting an estimated 16 million Americans, many of whom don’t know they have it. For years it was dismissed as “sensitive skin,” “adult acne,” or “just flushing easily.” The visible symptoms – persistent facial redness, bumps, and visible blood vessels – were addressed cosmetically rather than medically.

That picture has changed significantly. Rosacea is now understood as a chronic inflammatory condition with real underlying mechanisms, meaningful treatments, and – if left unmanaged – a tendency to progress and worsen over time. Understanding it properly changes what you do about it.

What Rosacea Is

Rosacea is a chronic inflammatory skin condition that primarily affects the central face – the cheeks, nose, forehead, and chin. It’s characterized by episodes of flushing, persistent redness, visible blood vessels (telangiectasia), and in many cases pimple-like bumps (papules and pustules) that can be mistaken for acne.

It’s not acne. The mechanisms are different, the treatments are different, and confusing the two leads to using products that don’t help and sometimes actively worsen rosacea.

Rosacea is a relapsing and remitting condition – it flares with triggers and settles with avoidance and treatment. Without proper management, it tends to worsen over time rather than resolve spontaneously. The redness that started as occasional flushing becomes persistent. The visible blood vessels multiply. In some people – particularly men – the skin of the nose can thicken progressively into what’s called rhinophyma.

The Four Subtypes

The National Rosacea Society and most dermatology guidelines recognize four subtypes of rosacea, which can overlap in the same person:

Subtype 1 – Erythematotelangiectatic rosacea (ETR): Flushing and persistent central facial redness, often with visible blood vessels (telangiectasia). The most common subtype. Skin may be sensitive and reactive – burning or stinging with topical products. No bumps or pustules.

Subtype 2 – Papulopustular rosacea: Persistent redness alongside acne-like breakouts – red bumps (papules) and pus-filled lesions (pustules). This is the subtype most commonly mistaken for acne. Unlike acne, there are no comedones (blackheads or whiteheads) in rosacea.

Subtype 3 – Phymatous rosacea: Skin thickening and irregular surface changes, most commonly affecting the nose (rhinophyma) but also the chin, forehead, cheeks, and ears. More common in men. Results from sebaceous gland enlargement and connective tissue overgrowth. Associated with longstanding, inadequately treated rosacea.

Subtype 4 – Ocular rosacea: Eye involvement – affecting approximately 50% of people with rosacea at some point. Symptoms include red, irritated, gritty, or burning eyes; sensitivity to light; recurrent styes; and blurred vision in more severe cases. Often overlooked because patients and providers don’t connect eye symptoms to their skin condition.

What Causes Rosacea

The exact cause of rosacea isn’t fully understood, but research has identified several converging mechanisms:

Neurovascular Dysregulation

The most fundamental feature of rosacea is dysregulation of the facial neurovascular system – the network of nerves and blood vessels controlling blood flow and flushing in the skin. In rosacea, this system is chronically overactivated:

• Blood vessels dilate more readily and remain dilated longer in response to stimuli that wouldn’t cause prolonged flushing in people without rosacea
• Neuropeptides (substance P, CGRP) are released in greater quantities, amplifying the flushing response
• Over time, repeated vascular dilation leads to permanent vessel enlargement and the persistent redness that characterizes established rosacea

Immune System Dysregulation and Inflammation

Rosacea involves chronic low-grade skin inflammation driven by an overactivated innate immune system. Specifically:

• Cathelicidins (antimicrobial peptides, particularly LL-37) are overproduced and abnormally processed in rosacea skin, generating inflammatory forms that trigger blood vessel growth and immune activation
• Toll-like receptor 2 (TLR2) signaling is upregulated in rosacea, amplifying inflammatory responses to environmental triggers
• Mast cells are elevated in rosacea skin, contributing to flushing, inflammation, and vascular changes

The Demodex Connection

Demodex folliculorum is a microscopic mite that lives in human hair follicles – a normal skin resident in everyone. People with rosacea have significantly higher Demodex densities than those without. Demodex may contribute to rosacea through:

• Triggering innate immune activation (TLR2 signaling) via bacterial proteins they carry (particularly Bacillus oleronius)
• Physical follicular disruption promoting inflammation

This is why ivermectin cream – which kills Demodex mites – is effective for papulopustular rosacea. The Demodex connection also explains why some people notice rosacea improvement after treating other conditions with ivermectin.

Genetic Factors

Rosacea has a clear genetic component – approximately 30-40% of people with rosacea have a first-degree relative with the condition. Several genetic variants have been identified, particularly involving the immune system and the vascular response to environmental triggers.

Skin Barrier Dysfunction

Rosacea skin has measurable impairment of the skin barrier – increased transepidermal water loss and reduced barrier integrity compared to normal skin. This contributes to the skin sensitivity characteristic of rosacea (burning, stinging, reactivity to products) and may allow environmental triggers to penetrate more easily.

Common Triggers

Rosacea doesn’t continuously flare at the same intensity – it’s triggered by specific stimuli that produce flushing and inflammation. The most consistent triggers across the rosacea population:

Temperature extremes: Hot weather, cold wind, saunas, hot baths, exercise in heat – anything that raises facial temperature and blood flow

Sun exposure: UV radiation is one of the most potent and consistent rosacea triggers – it drives both flushing and long-term worsening

Spicy food: Capsaicin in chili peppers directly activates TRPV1 receptors in facial nerves, triggering flushing

Alcohol: Particularly red wine, which contains multiple flushing triggers including histamine, tannins, and sulfites. Alcohol is among the most commonly reported triggers.

Hot beverages: Temperature rather than caffeine is the primary issue – the flushing response to hot drinks is the same whether caffeinated or not

Emotional stress: Stress triggers the same neurovascular pathways as other stimuli

Certain skincare products: Products containing alcohol, witch hazel, fragrances, menthol, or exfoliating acids can aggravate rosacea skin

Exercise: Particularly vigorous exercise that raises core body temperature significantly

Trigger identification is individual – keeping a symptom diary linking flares to exposures helps identify personal triggers, which vary meaningfully between people.

Who Gets Rosacea

Rosacea is most common in:

• Adults aged 30-60
• People with fair skin, light hair, and light eyes
• Women (more frequently diagnosed) though men tend to develop more severe disease including rhinophyma
• People with a family history of rosacea
• Those of Northern European or Celtic descent

However, rosacea affects people of all skin tones – it’s significantly underdiagnosed in people with darker skin, partly because redness is less visible and partly because the condition has historically been studied and described primarily in fair-skinned populations. In darker skin tones, rosacea may present more prominently as papules and pustules, burning and stinging, or thickened skin texture rather than visible redness.

Rosacea vs Acne: The Key Differences

This distinction is clinically important because the wrong treatment can worsen rosacea:

Benzoyl peroxide, salicylic acid, and strong retinoids – effective for acne – frequently worsen rosacea by irritating the already-compromised skin barrier. This is one of the most common treatment errors when rosacea is mistaken for acne.

Treatment: What the Evidence Shows

Rosacea cannot be cured, but it can be effectively controlled. Treatment is matched to subtype.

Trigger Avoidance

The foundation of rosacea management regardless of subtype. Identifying and consistently avoiding personal triggers produces meaningful reduction in flare frequency and severity. Sun protection is the single most universally applicable intervention – broad-spectrum SPF 30+ sunscreen daily, physical blockers (zinc oxide, titanium dioxide) are generally better tolerated by rosacea skin than chemical UV filters.

Topical Treatments

Metronidazole (MetroGel, MetroCream): A topical antibiotic/anti-inflammatory – first-line topical treatment for papulopustular rosacea. Reduces papules and pustules and has modest effect on redness.

Azelaic acid (Finacea, Azelex): Anti-inflammatory and mildly antimicrobial. Effective for both papulopustular and erythematotelangiectatic subtypes. Well-tolerated by sensitive skin. Available OTC at 10% and prescription at 15-20%.

Ivermectin 1% cream (Soolantra): Anti-parasitic that reduces Demodex mites. Strong evidence for papulopustular rosacea – multiple trials show it outperforms metronidazole for lesion reduction. Once-daily application.

Brimonidine gel (Mirvaso) and oxymetazoline cream (Rhofade): Topical alpha-adrenergic agonists that cause immediate vasoconstriction, reducing facial redness within 30 minutes. Provide temporary (8-12 hour) redness reduction rather than treating underlying disease. Rebound redness can occur after wearing off. Used for episodic redness control.

Topical retinoids: Generally used cautiously in rosacea due to irritation potential, particularly in subtype 1. Low concentrations may be useful for subtype 3 (phymatous) but typically require careful introduction.

Oral Treatments

Doxycycline (Oracea): Sub-antimicrobial dose doxycycline (40mg modified-release) is FDA-approved for papulopustular rosacea. At this dose it acts as an anti-inflammatory rather than antibiotic – reducing the inflammatory pathways without creating antibiotic resistance. More effective than standard antibiotic courses for long-term rosacea management.

Standard-dose antibiotics (doxycycline 100mg, tetracycline, azithromycin): Used for moderate-to-severe papulopustular rosacea flares, typically for 6-12 weeks followed by maintenance with topical agents. Antibiotic courses should be minimized given resistance concerns.

Isotretinoin: For severe, treatment-resistant rosacea – particularly phymatous subtype. At low doses (lower than used for acne), isotretinoin reduces sebaceous gland activity and can produce lasting improvement. Requires strict pregnancy prevention due to teratogenicity.

Beta-blockers (propranolol, carvedilol): For prominent flushing – reducing the adrenergic component of the flush response. Useful for neurogenic flushing subtype.

Laser and Light Treatments

Pulsed dye laser (PDL) and intense pulsed light (IPL): Most effective treatments for persistent redness and telangiectasia. Target oxyhemoglobin in dilated vessels, causing vessel destruction and resolution of redness. Multiple sessions typically needed. Significant improvement in erythematotelangiectatic rosacea that doesn’t respond adequately to topical treatment.

CO2 laser, electrosurgery: For rhinophyma and skin thickening – reshaping and removing excess tissue.

Skincare for Rosacea

Rosacea skin requires a simplified, gentle skincare approach:

• Gentle, fragrance-free, non-foaming cleanser
• Moisturizer with barrier-supporting ingredients (ceramides, hyaluronic acid, niacinamide)
• SPF 30+ mineral sunscreen daily (zinc oxide/titanium dioxide)
• Avoiding products with alcohol, witch hazel, menthol, eucalyptus, fragrances, and most chemical exfoliants
• Niacinamide (vitamin B3) at 4-5% is one of the best-tolerated active ingredients for rosacea – anti-inflammatory, barrier-supporting, and improves redness with regular use

Ocular Rosacea: Don’t Overlook the Eyes

Ocular rosacea is present in approximately 50% of people with cutaneous rosacea and is often undertreated because the connection isn’t made. Symptoms include:

• Chronically red, irritated, or gritty-feeling eyes
• Burning or stinging eyes
• Recurrent styes (hordeola) or chalazia
• Sensitivity to light
• Blurred vision in more severe cases

Management includes: warm compresses, eyelid hygiene (cleaning the lid margins), omega-3 fatty acid supplementation (evidence for meibomian gland dysfunction), lubricating eye drops, topical or oral antibiotics for inflammatory cases, and cyclosporine eye drops for moderate-to-severe disease.

Ocular rosacea that isn’t recognized and treated can – rarely – cause corneal damage and vision impairment. Any eye symptoms in the context of facial rosacea warrant ophthalmology involvement.

Frequently Asked Questions

Is rosacea an autoimmune condition? Not in the traditional sense – rosacea doesn’t involve autoantibodies or the adaptive immune system attacking self-tissue in the way autoimmune conditions like lupus or rheumatoid arthritis do. However, it does involve dysregulation of the innate immune system, and it’s more common in people with autoimmune conditions. It’s best described as a chronic inflammatory condition with immune dysregulation rather than a true autoimmune disease.

Will rosacea go away on its own? Rosacea is a chronic condition that doesn’t resolve spontaneously. Without treatment and trigger management, it tends to worsen over time. Early treatment is important to prevent the permanent vascular changes and skin thickening that develop with long-standing unmanaged rosacea.

Can diet improve rosacea? Beyond avoiding specific dietary triggers (spicy food, alcohol, hot beverages), some evidence supports anti-inflammatory dietary patterns for rosacea. Omega-3 fatty acids (from fatty fish, flaxseed, walnuts, or supplements) may reduce inflammation and improve meibomian gland function for ocular rosacea. A diet rich in antioxidants and low in processed foods may have modest benefits. No specific diet has strong evidence for rosacea cure, but dietary trigger management combined with an anti-inflammatory approach is reasonable.

Is rosacea made worse by alcohol? Yes – alcohol is among the most consistently reported dietary triggers for rosacea flares. Red wine appears to be particularly problematic, containing histamine, tannins, and sulfites alongside the vasodilatory effect of alcohol itself. White wine and spirits are less commonly reported as triggers than red wine, but any alcohol can worsen rosacea in susceptible individuals.

What’s the difference between rosacea and lupus butterfly rash? Both conditions produce facial redness in a similar distribution (cheeks and nose). Key differences: lupus rash (malar rash) tends to spare the nasolabial folds and is associated with systemic lupus symptoms (joint pain, fatigue, photosensitivity affecting non-facial areas). Rosacea involves the nasolabial folds and produces papules, pustules, and telangiectasia not typical of lupus rash. ANA and other lupus antibody tests are negative in rosacea. A dermatologist can distinguish these clinically, but blood tests are sometimes needed when the diagnosis is uncertain.

Disclaimer

This article is for educational purposes only and does not constitute medical advice. Rosacea diagnosis and management should be directed by a qualified healthcare provider or dermatologist, particularly for moderate-to-severe disease, ocular involvement, or cases that don’t respond to initial treatment.

References

1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. Journal of the American Academy of Dermatology. 2002;46(4):584-587. https://doi.org/10.1067/mjd.2002.120625
2. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. Journal of the American Academy of Dermatology. 2013;69(6 Suppl 1):S15-26. https://doi.org/10.1016/j.jaad.2013.04.045
3. Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea. British Journal of Dermatology. 2017;176(2):431-438. https://doi.org/10.1111/bjd.14699
4. van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. Interventions for rosacea. Cochrane Database of Systematic Reviews. 2015;(4):CD003262. https://doi.org/10.1002/14651858.CD003262.pub5
5. Taieb A, Ortonne JP, Ruzicka T, et al. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea. British Journal of Dermatology. 2015;172(4):1103-1110. https://doi.org/10.1111/bjd.13498
6. American Academy of Dermatology (AAD). Rosacea: diagnosis and treatment. https://www.aad.org/public/diseases/a-z/rosacea-treatment
7. National Rosacea Society. All about rosacea. https://www.rosacea.org/rosacea-101/what-is-rosacea
8. Bewley A, Fowler J, Schöfer H, Girard C, Passi S. Erythema of rosacea impairs health-related quality of life. Dermatology and Therapy. 2016;6(2):237-247. https://doi.org/10.1007/s13555-016-0106-9
9. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. Journal of the American Academy of Dermatology. 2015;72(5):749-758. https://doi.org/10.1016/j.jaad.2014.08.028
10. MedlinePlus. Rosacea. https://medlineplus.gov/rosacea.html